Universal Display Corporation: Q3 2022 Form 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Revenue is primarily generated from OLED material sales, royalty and license fees, and contract research services through Adesis. The unaudited report covers the three and nine months ended September 30, 2022, compared with the corresponding 2021 periods.
Commercial operations commenced at the new Shannon, Ireland manufacturing facility in June 2022. When fully operational, the facility is expected to double production capacity and diversify the manufacturing base.
Key Financial Metrics
| Metric | Q3 2022 | Q3 2021 | Change |
|---|---|---|---|
| Total revenue | $160.6 million | $143.6 million | +11.8% |
| Gross profit | $123.2 million | $112.1 million | +9.8% |
| Gross margin | 76.7% | 78.1% | Down 1.4 points |
| Operating income | $68.5 million | $57.7 million | +18.6% |
| Net income | $53.5 million | $46.1 million | +15.9% |
| Diluted EPS | $1.12 | $0.97 | +15.5% |
| Cash dividend per share | $0.30 | $0.20 | +50.0% |
| Metric | Nine Months 2022 | Nine Months 2021 | Change |
|---|---|---|---|
| Total revenue | $447.6 million | $407.3 million | +9.9% |
| Gross profit | $349.8 million | $324.5 million | +7.8% |
| Gross margin | 78.2% | 79.7% | Down 1.5 points |
| Operating income | $184.0 million | $171.2 million | +7.5% |
| Net income | $144.9 million | $138.3 million | +4.8% |
| Diluted EPS | $3.04 | $2.90 | +4.8% |
Q3 revenue consisted of $84.2 million of material sales, $71.5 million of royalty and license fees, and $4.9 million of contract research services. For the first nine months, these categories contributed $242.7 million, $191.5 million and $13.3 million, respectively.
Research and development expense increased to $30.4 million in Q3 and $85.2 million for the nine months, reflecting higher employee-related costs, PPG development activity, OVJP technology development and contract research. Q3 selling, general and administrative expense declined to $18.4 million, while nine-month expense increased modestly to $59.4 million.
Cash Flow, Liquidity and Capital Structure
- Cash provided by operating activities was $124.2 million for the nine months ended September 30, 2022, compared with $134.3 million in the prior-year period.
- Cash used in investing activities was $197.8 million, primarily reflecting net purchases of investments, capital expenditures and intangible asset purchases.
- Cash used in financing activities was $50.6 million, including $42.7 million of cash dividends and $9.2 million of employee tax withholding payments.
- Cash and cash equivalents were $187.8 million, short-term investments were $501.1 million, and long-term investments were $173.9 million at September 30, 2022. Total cash and investments were approximately $862.7 million, including minority investments and convertible notes.
- Working capital was $839.0 million, compared with $738.0 million at December 31, 2021.
- The filing does not disclose outstanding conventional borrowings or debt financing. Total liabilities were $318.5 million, including deferred revenue, retirement plan benefit liabilities, taxes payable and lease obligations.
- Management expects existing cash, cash equivalents and short-term investments to fund obligations for at least the next 12 months.
Material Changes Versus the Prior Comparable Period
- Q3 material sales increased 11% and unit material volume increased 8%. Green emitter sales rose to $64.0 million and red emitter sales rose to $20.0 million.
- Nine-month material sales increased 4%, with unit volume up 5%; royalty and license revenue increased 17%.
- Revenue benefited from higher unit volumes, customer mix and cumulative catch-up adjustments related to changes in estimated transaction prices. The catch-up adjustment was $6.6 million in Q3 and $17.3 million for the nine-month period.
- Gross margin declined because of higher per-unit material costs, inventory reserves and underutilization of the Shannon facility. Shannon underutilization charges were $3.4 million in Q3 and $4.5 million for the nine months.
- Income tax rates increased to 23.7% from 20.2% in Q3 and to 22.7% from 19.4% for the nine months, partly because of changes involving Chinese withholding tax credits and capitalization of research and development costs.
- Interest income increased materially because of higher investment balances and bond yields.
- Fujifilm acquired technology became fully amortized in 2022, reducing amortization expense by $1.9 million in Q3 and $1.9 million for the nine months.
- Inventory increased to $180.2 million from $134.2 million at year-end 2021, while deferred revenue declined to $94.0 million from $157.1 million.
Guidance, Outlook, Risks and Unusual Items
- No specific numerical revenue or earnings guidance is provided.
- Management expects the Shannon facility to remain underutilized in the near term as capacity is brought online ahead of anticipated growth.
- Management continues to cite uncertainty from COVID-19, global economic deterioration, inflation, higher interest rates, consumer demand, supply-chain and logistics constraints, and customer production requirements. The filing states that these factors may adversely affect revenue, net income and cash flow through at least the end of Q4 2022.
- Three customers represented 81% of Q3 revenue and 82% of nine-month revenue. South Korea and China accounted for approximately 97% of revenue outside North America.
- Substantially all chemical materials were purchased from one supplier, and inventory purchase commitments were $36.6 million at September 30, 2022.
- The company had $25.5 million of committed phosphorescent emitter material backlog, expected to be fulfilled within 90 days.
- A Korean withholding-tax refund process remains pending, although the company was notified after quarter-end that the Korean tax authority was processing refunds expected within the next quarter. Related tax assets and liabilities were recorded based on management estimates.
- An opposition proceeding involving European Patent No. 1390962 was resolved in September 2022 in favor of validity based on amended claims. The patent had expired under its original term, and management did not expect the proceeding to materially affect the business.
- Management reported no material changes to previously disclosed risk factors, no off-balance-sheet arrangements and no material changes affecting internal control over financial reporting.
- The Board declared a fourth-quarter dividend of $0.30 per share payable December 30, 2022.
Most Important Facts for Investors to Verify
- Whether OLED customer demand, particularly in mobile and television markets, supports the company’s volume and royalty assumptions.
- The sustainability of the $6.6 million Q3 and $17.3 million year-to-date revenue catch-up adjustments and the effect of revised customer demand estimates.
- The pace at which the Shannon facility reaches utilization sufficient to offset current underutilization charges.
- Customer concentration, geographic concentration and reliance on a single chemical-material supplier.
- Inventory levels, excess inventory reserves and the conversion of deferred revenue and backlog into future sales.
- The timing and amount of Korean tax refunds, related U.S. tax obligations and potential changes in recorded tax assets or liabilities.
- Cash deployment for investments, manufacturing expansion, research and development, dividends and potential future financing needs.